NAD+observational1987

Photolabelling of cholera toxin by NAD+.

The Biochemical journal

confidence

Key findings

NAD+ photolabels active A1 chain of cholera toxin under UV; specific, inhibited by excess NAD; both NAD moieties bind; no biological endpoint.

View source on PubMed (PMID 3593286) ↗

Population
In vitro (cholera toxin incubation)
Dosing
NAD+ labelled in adenine or nicotinamide moiety
Route
in vitro incubation
Blinding
not_reported
Controls
none
Drug class
coenzyme
Full abstract

When cholera toxin is incubated under u.v. light with NAD+ labelled in either the adenine or the nicotinamide moiety, radioactivity becomes covalently bound to the protein. The reaction is specific for cholera toxin, and is inhibited by excess unlabelled NAD+ or NAD analogues. Only the active A 1 chain of the toxin is labelled. The u.v.-absorption spectrum of the product is very similar to that of NAD+, and shows the same reaction with cyanide. The nature of the product is therefore different from that found when diphtheria toxin is photolabelled [Carroll & Collier (1984) Proc. Natl. Acad. Sci. U.S.A. 81, 3307-3311] in that the yield is lower, but both moieties of the NAD molecule become bound.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.